Skip to main content
S 713 105th Congress Senate

Better Pharmaceuticals for Children Act

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for additional deferred effective dates for approval of applications under the new drugs provisions, and for other purposes.

Introduced: June 9, 1997 See on congress.gov
Health Child healthClinical trialsCommerceCongress
More subjectsShow fewer subjects
Congressional reporting requirementsDrug approvalsDrug industryEconomic impact statementsEconomics and Public FinanceFamiliesGovernment Operations and PoliticsGovernment paperworkGovernment publicityMedical researchPharmaceutical researchScience, Technology, Communications
Sign in to write a letter Sign in to watch
This bill died when the 105th Congress ended
It never became law before the 105th Congress (1997–1998) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 9, 1997
Sponsor introductory remarks on measure. (CR S4276-4277)
May 7, 1997
Read twice and referred to the Committee on Labor and Human Resources.
May 7, 1997
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 9, 1997

Sponsor introductory remarks on measure. (CR S4276-4277)

 Plain-English summary Congressional Research Service

Better Pharmaceuticals for Children Act - Amends the Federal Food, Drug, and Cosmetic Act to allow for additional deferred effective dates for the approval of certain new drug applications to allow for additional pediatric information developed by further studies. Mandates development, publication, and annual updating of a list of approved drugs for which additional pediatric information may produce health benefits in the pediatric population.

 Related & companion bills 1
  • HR 1727 Identical bill Better Pharmaceuticals for Children Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Collins, Susan M.
Maine · Jun 9, 1997
Cite this page click to expand
APA
U.S. Congress. (2026). S. 713: Better Pharmaceuticals for Children Act. 105th Congress. Open America. https://openamerica.io/bill/105-S-713/
MLA
"S. 713: Better Pharmaceuticals for Children Act." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-S-713/.
Bluebook (legal)
S. 713, 105th Cong. (2026), https://openamerica.io/bill/105-S-713/.
Markdown link
[S. 713: Better Pharmaceuticals for Children Act](https://openamerica.io/bill/105-S-713/)
Report a problem